Paul Chatrath was an invited member on the International Advisory Board for Allergen, the company that manufactures the Earfold™ implant for prominent ear correction. Mr Chatrath was one of five experts invited to the conference in which the patient pathway from presentation right up to a decision to undergo prominent ear correction surgery was discussed in detail. This included analysis of complex cases and an in depth appraisal of the Earfold™ implant and its role in the management of prominent ears.
Paul was one of three expert assessors at the Royal Society of Medicine Trainee Sinus Dissection Prize Day. This was the first such occasion at which senior surgical trainees in ENT Surgery were invited to participate in a day of advanced dissections, with the quality of the surgical dissections being assessed carefully by the three assessors and a Prize given for the dissection judged to be the best. This was a very successful day of training and assessment and will hopefully be repeated in future years.
Paul was invited to attend a National Epistaxis Consensus Day in Leeds, UK. He was one of several invited experts gathered to consider the evidence for various aspects of the treatment pathway for patients with nose bleeds requiring admission to hospital, with the aim of formulating some common guidelines to try to reduce variability and raise standards in the treatment of this condition throughout the UK.
Paul attended the University of Pennsylvania Advanced Skull Base Dissection and Rhinoplasty Courses as an international guest. This was a 4 day intensive course aimed at refining advanced surgical skills in complex situations.